Related Experiment Videos
Octreotide in acute bleeding esophageal varices: a prospective randomized study
D S Freitas1, C Sofia, J M Pontes
1Gastroenterology Department, Coimbra University Hospital, Portugal.
Hepato-Gastroenterology
|December 2, 2000
Summary
Octreotide infusion effectively controls acute esophageal variceal bleeding. It is as effective as sclerotherapy for recent bleeding and a valuable addition to sclerotherapy for active bleeding.
Area of Science:
- Gastroenterology
- Hepatology
- Clinical Pharmacology
Background:
- Esophageal varices are a serious complication of portal hypertension, often leading to life-threatening bleeding.
- Effective hemostasis is crucial in managing acute variceal bleeding to prevent rebleeding and reduce mortality.
Purpose of the Study:
- To evaluate the efficacy of octreotide in controlling acute esophageal variceal bleeding.
- To compare octreotide with emergency sclerotherapy and its combination with sclerotherapy.
Main Methods:
- A prospective randomized study involving 197 patients with confirmed variceal bleeding.
- Patients were divided into two groups based on bleeding status: recent stigmata or active bleeding.
- Treatment arms included octreotide infusion, emergency sclerotherapy, or a combination of sclerotherapy and octreotide.
Main Results:
- Octreotide demonstrated comparable hemostasis to sclerotherapy in patients with recent bleeding.
- In active bleeding, octreotide combined with sclerotherapy significantly improved hemostasis compared to sclerotherapy alone.
- Reduced transfusion requirements were observed in patients receiving the octreotide-sclerotherapy combination.
Conclusions:
- Octreotide infusion is an effective treatment for acute variceal bleeding.
- It serves as a viable alternative to emergency sclerotherapy for recent bleeding.
- Octreotide is a valuable adjuvant therapy when combined with emergency sclerotherapy for active variceal bleeding.